Lexeo Therapeutics Stock (NASDAQ: LXEO) stock price, news, charts, stock research, profile.
Open | $18.810 |
Close | - |
Volume / Avg. | 76.962K / 150.924K |
Day Range | 17.215 - 18.810 |
52 Wk Range | 9.000 - 22.330 |
Market Cap | $618.055M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 1.84% |
Days to Cover | 3.66 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lexeo Therapeutics (NASDAQ:LXEO) through any online brokerage.
Other companies in Lexeo Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Zentalis Pharma (NASDAQ:ZNTL), Larimar Therapeutics (NASDAQ:LRMR), PepGen (NASDAQ:PEPG) and Replimune Group (NASDAQ:REPL).
There is no analysis for Lexeo Therapeutics
The stock price for Lexeo Therapeutics (NASDAQ: LXEO) is $17.5 last updated Today at June 14, 2024 at 11:10 AM EDT.
There are no upcoming dividends for Lexeo Therapeutics.
Lexeo Therapeutics’s Q2 earnings are confirmed for Wednesday, August 21, 2024.
There is no upcoming split for Lexeo Therapeutics.
Lexeo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.